• Western blot analysis of lysates from wild type (WT) and C21orf33 knockout (KO) 293T cells, using [KO Validated] C21orf33 Rabbit polyclonal antibody (STJ11100847) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25 Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 1s.

Anti-C21orf33 antibody (42-268) (STJ11100847)

SKU:
STJ11100847

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.01% Thimerosal, 50% Glycerol, pH 7.3.
Purification: Affinity purification
Concentration: Lot specific
Dilution Range: WB:1:500-1:2000
ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements.
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: GATD3
Gene ID: 8209
Uniprot ID: GAL3A_HUMAN
Immunogen Region: 42-268
Specificity: Recombinant fusion protein containing a sequence corresponding to amino acids 42-268 of human C21orf33 (NP_004640.4).
Immunogen Sequence: AARVALVLSGCGVYDGTEIH EASAILVHLSRGGAEVQIFA PDVPQMHVIDHTKGQPSEGE SRNVLTESARIARGKITDLA NLSAANHDAAIFPGGFGAAK NLSTFAVDGKDCKVNKEVER VLKEFHQAGKPIGLCCIAPV LAAKVLRGVEVTVGHEQEEG GKWPYAGTAEAIKALGAKHC VKEVVEAHVDQKNKVVTTPA FMCETALHYIHDGIGAMVRK VLELTGK
Protein Name Glutamine Amidotransferase-Like Class 1 Domain-Containing Protein 3 - Mitochondrial
Cellular Localisation Mitochondrion
Alternative Antibody Names Anti-Glutamine Amidotransferase-Like Class 1 Domain-Containing Protein 3 - Mitochondrial antibody
Anti-GATD3 antibody
Anti-C21orf33 antibody
Anti-GATD3A antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance